EUVIMEDEUVIMED entdecken
Crossref

Reaching the target: time and dose required to achieve target vancomycin plasma concentrations in admitted patients

W Töpfer, K H M Larmené-Beld, G J Veen, J D Machiels, E J Smolders

Journal of Antimicrobial Chemotherapy · 2026

DOI: 10.1093/jac/dkaf424 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von W Töpfer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unit of PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, The Netherl…. Hauptthemen laut MEDLINE: Vancomycin, Anti-Bacterial Agents. Die Arbeit nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

In our hospital, patients are treated with continuous vancomycin infusion following standard dosing guidelines. Recent literature suggests that obese and neutropenic patients may require increased vancomycin dosages. This study aimed to reassess our dosing guidelines by evaluating how the time and dose required to achieve vancomycin target concentrations differ across specific patient groups compared to all vancomycin patients.

Methods

A retrospective cohort study was conducted using hospital records from patients treated with continuous vancomycin infusion between 1 January and 31 December 2023. Adult patients treated according to the antibiotic guidelines, with at least one vancomycin target concentration measurement, were included. We compared the time and maintenance dose required to reach target concentrations in neutropenic patients (neutrophils <1.5 × 109/L), patients weighing >100 kg, patients with augmented renal clearance (ARC; glomerular filtration rate >130 mL/min/1.73 m2) and all vancomycin patients.

Results

The median time to reach target was 2.59 days for all vancomycin patients (n = 244), and 2.73, 2.74, and 3.39 days for ARC patients (n = 5), neutropenic patients (n = 15) and patients weighing >100 kg (n = 50), respectively. The median maintenance dose was 2000 mg/day among all vancomycin patients, compared to 3000 mg/day for patients weighing >100 kg and neutropenic patients and 4000 mg/day for ARC patients.

Conclusions

According to current guidelines, there is no significant difference in the time required to achieve vancomycin target concentrations between neutropenic patients, ARC patients and all vancomycin patients. However, patients weighing >100 kg took nearly a day longer to reach target concentrations (P < 0.001) and required higher maintenance doses, as did neutropenic and ARC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinAnti-Bacterial AgentsHumansRetrospective StudiesMaleFemaleMiddle AgedAgedNeutropeniaAdultAged, 80 and overTime FactorsInfusions, Intravenous

Substanzen

VancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Unit of PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, The Netherlands.
  • Department of Clinical Pharmacy, Isala Hospital, Dr. van Heesweg 2, Zwolle 8025AB, The Netherlands.
  • Department of Medical Microbiology and Infection Prevention, Isala Hospital, Zwolle, The Netherlands.

Zitieren

APA

Töpfer, W., Larmené-Beld, K. H. M., Veen, G. J., Machiels, J. D., & Smolders, E. J. (2026). Reaching the target: time and dose required to achieve target vancomycin plasma concentrations in admitted patients. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf424

Vancouver

Töpfer W, Larmené-Beld KHM, Veen GJ, Machiels JD, Smolders EJ. Reaching the target: time and dose required to achieve target vancomycin plasma concentrations in admitted patients. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkaf424

BibTeX
@article{Tpfer2026,
  author = {Töpfer, W and Larmené-Beld, K H M and Veen, G J and Machiels, J D and Smolders, E J},
  title = {Reaching the target: time and dose required to achieve target vancomycin plasma concentrations in admitted patients},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  doi = {10.1093/jac/dkaf424}
}
Kostenlos starten →